Gemifloxacin

Gemifloxacin represents a prominent fourth-generation oral fluoroquinolone antibiotic. It is predominantly used in treating mild-to-moderate respiratory tract infections instigated by susceptible organisms.
Mechanism of Action[edit]
Gemifloxacin, like its fluoroquinolone counterparts, boasts an expansive activity spectrum against aerobic gram-positive and gram-negative organisms. Its mechanism of action primarily revolves around inhibiting type II DNA topoisomerases (gyrases). These enzymes are instrumental in synthesizing bacterial mRNAs (transcription) and DNA replication.
FDA Approval Information[edit]
The FDA sanctioned the medical use of Gemifloxacin in the United States in the year 2003. However, its adoption rate has been somewhat overshadowed by other more commonly used fluoroquinolones, such as ciprofloxacin and levofloxacin. As of current medical directives, Gemifloxacin is prescribed for conditions like acute exacerbations of chronic bronchitis and community-acquired pneumonia.
Dosage and Administration[edit]
Gemifloxacin is commercially available under the brand name 'Factive' and is dispensed in 320 mg tablet form. The recommended dosage for patients is 320 mg, administered once daily, spanning 5 to 7 days.
Side Effects[edit]
Like any therapeutic drug, Gemifloxacin comes with its set of side effects. Some common side effects experienced by users include:
Moreover, while less frequent, certain severe side effects associated with the fluoroquinolones class have been reported. These encompass:
- prolongation of the QT interval
- seizures
- hallucinations
- tendon rupture
- angioedema
- photosensitivity
Liver Safety[edit]
While Gemifloxacin is predominantly safe, it has, in rare circumstances, been associated with instances of acute liver injury.
See Also[edit]
List of flouroquinolones[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian